Breaking News

Bilcare, CSIR in Authentication Technology Pact

Will advance nonClonableID technology

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Council of Scientific and Industrial Research (CSIR), under its New Millennium Indian Technology Leadership Initiative (NMITLI), has approved the implementation of customized adaptation of nonClonableID technology to establish authenticity of medical products. Dr. Praful Naik, executive director and chief scientific officer of Bilcare Ltd., has been designated principal investigator for the project.   The CSIR-NMITLI-Bilcare team will work to demonstrate the ability of a new nonClonableID techno...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters